Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06895070 · ClinicalTrials.gov registry record · NA

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

A NA study of Heart Failure and Heart Transplant, sponsored by XVIVO Perfusion.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
14
Study locations

NCT06895070 is a NA study of Heart Failure and Heart Transplant that is actively recruiting participants, run by XVIVO Perfusion. The registered enrollment target is 60 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The trial reports 14 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06895070, a NA study of Heart Failure and Heart Transplant, is actively recruiting participants, sponsored by XVIVO Perfusion.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
14
Study locations

Study Summary

The purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.

Conditions Studied

Heart Failure Heart Transplant Transplant; Failure, Heart

Interventions

  • DEVICE Non-Ischemic Heart Preservation (NIHP) using the XVIVO Heart Assist Transport (XHAT)

Study Locations (14)

California

  • UC San Diego Health - La Jolla
  • Cedars Sinai Medical Center - Los Angeles
  • University of California Los Angeles - Los Angeles
  • Stanford University - Stanford

New York

  • NYU Langone - New York
  • Columbia University Medical Center/New York Presbyterian Hospital - New York

Georgia

  • Emory University Hospital - Atlanta

Illinois

  • Northwestern Memorial Hospital - Chicago

Missouri

  • Washington University - Barnes Jewish Health Hospital - St Louis

Nebraska

  • University of Nebraska Medical Center - Omaha

North Carolina

  • Duke University Medical Center - Durham

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-07-10
Est. Completion 2031-05
Phase NA

Sponsor

XVIVO Perfusion

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06895070

The ClinicalTrials.gov registry entry for NCT06895070 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The listed sponsor is XVIVO Perfusion, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Non-Ischemic Heart Preservation (NIHP) using the XVIVO Heart Assist Transport (XHAT) is the first listed.

NCT06895070 reports 14 study locations spanning 10 distinct geographic areas - top geographies include California, New York, Georgia.

Frequently Asked Questions

What is clinical trial NCT06895070 about?

NCT06895070 is a clinical study titled "XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)". The purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.

What is the current status of trial NCT06895070?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-07-10. Estimated completion is 2031-05.

What conditions does trial NCT06895070 study?

This clinical trial studies the following conditions: Heart Failure, Heart Transplant, Transplant; Failure, Heart.

What interventions are being tested in trial NCT06895070?

The interventions under investigation include: Non-Ischemic Heart Preservation (NIHP) using the XVIVO Heart Assist Transport (XHAT) (DEVICE).

Who is sponsoring clinical trial NCT06895070?

This trial is sponsored by XVIVO Perfusion, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06895070 being conducted?

This trial has 14 study locations across California, Georgia, Illinois, Missouri, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Heart Failure

All registered trials for this condition

Heart Transplant

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.